Vivani Medical, Inc.
Financial highlights
| Metric | FY December 31, 2025 | FY December 31, 2024 | FY December 31, 2023 | FY December 31, 2022 | FY December 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | — | — | — |
| Gross profit | — | — | — | — | $130,000 |
| Operating income | -$27.6M | -$24.7M | -$27.0M | -$21.2M | -$13.3M |
| Operating expenses | $27.6M | $24.7M | $27.0M | $21.2M | $13.3M |
| Cost of revenue | — | — | — | — | $130,000 |
| Cash from operations | -$24.3M | -$20.8M | -$23.7M | -$18.8M | -$11.0M |
| Capital expenditure | $1.2M | $556,000 | $887,000 | $338,000 | $572,000 |
| Free cash flow | -$25.5M | -$21.3M | -$24.6M | -$19.1M | -$11.5M |
| Impairments | — | — | — | — | $700,000 |
| Total assets | $39.4M | $41.6M | $45.8M | $51.1M | $5.5M |
| Total liabilities | $23.7M | $24.0M | $25.0M | $6.8M | $3.0M |
Shares outstanding 86.2M · Free float 31.0%
Annual filing data through FY ended December 31, 2025; float as of July 12, 2026.